RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of...( IRVING Texas Jan. 5 /- The promot...),Health

IRVING, Texas, Jan. 5 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC Bulletin Board: RBCL) announced today that it has elected current president, John W. Price, to CEO effective January 1, 2009. Company founder, Clinton Howard, who is currently CEO, will remain as chairman of the board of directors.

The promotion comes at a time when RBC Life Sciences, a global provider of proprietary nutritional supplements, wound care and pain management products, is growing domestically and internationally. The company announced recently that third quarter net sales and earnings both increased 26 percent over the same period last year.

"John possesses the perfect skill set to take RBC Life Sciences to the next level," said Mr. Howard, who founded the company in 1991. "He has the vision, leadership and focus needed to pilot a multinational company to the forefront of its industry."

A retired U.S. naval commander, Price was named president of RBC Life Sciences in December 2007. He will retain the position of president after being promoted to CEO January 1. Prior to joining the company, he served as a senior executive for two major companies that market nutritional supplements domestically and internationally. Price also led a successful management consulting company and spent 17 years as a senior officer of pharmaceutical giant Eli Lilly.

"It's an exciting time for RBC Life Sciences," said Price, a triathlon athlete who practices the healthy nutrition and exercise promoted by the company. "We're redoubling our efforts to grow our North American market while undertaking aggressive international expansion. We have a healthy balance sheet driven by sales of nutritional supplements and medical device products that are backed by science and are receiving increasing accolades within their industries."

The company's medical devices brand
'/>"/>